Physician profile
Jared Lancaster
NPI 1609249127
$2,176.03
in general payments reported to CMS, 2019-2025
16 companies · $391 in 2025
The $391 reported for 2025 was more than what 75% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $360 · 2022: $500 · 2023: $420 · 2024: $506 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,316.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $841.34 | 2022-2025 | Jetstream Sc, Ranger, General - Balloons |
| Chiesi USA, INC. | $212.92 | 2021-2023 | Cleviprex, Kengreal |
| Penumbra, INC. | $210.93 | 2022-2023 | Indigo System |
| Abbott Laboratories | $144.60 | 2021-2023 | Xience Skypoint |
| Astrazeneca Pharmaceuticals LP | $136.24 | 2021-2023 | Farxiga |
| Inari Medical, INC. | $120.74 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $94.66 | 2021-2023 | Diamondback Coronary |
| Bard Peripheral Vascular, INC. | $76.97 | 2021 | |
| Novartis Pharmaceuticals Corporation | $72.32 | 2022-2025 | |
| Medtronic, INC. | $68.37 | 2024 | Hawkone |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.60 | 2022 | |
| Surmodics, INC. | $55.66 | 2024 | Pounce Thrombectomy, Pounce LP Thrombectomy, Pounce Venous Thrombectomy System |
| Angiodynamics, INC. | $24.18 | 2022 | |
| Edwards Lifesciences Corporation | $23.79 | 2025 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $22.11 | 2024 | Xarelto |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Lancaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.